About Innocoll

Innocoll is a specialty pharmaceutical company committed to improving the status quo and finding answers to unmet needs

XARACOLL®

Our lead investigational product is a drug-device surgical implant being developed for potential uses in addressing postsurgical pain

Latest News

Innocoll Holdings Limited Appoints Richard Fante as Chief Executive Officer

ATHLONE, Ireland & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Innocoll Holdings Limited (“Innocoll”), a specialty pharmaceutical company wholly owned by Gurnet Point Capital, announced...
Read More

Innocoll and Gurnet Point Announcement relating to the Scheme becoming Effective

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO...
Read More

Innocoll Announcement Relating to the Outcome of the Court Sanction Hearing

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO...
Read More